Showing results (91-100 of 380) with videos related to

Sort By:
Pageof 38
American Journal of Hematology|May 15, 2021
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemiaNitin Jain, Abhishek Maiti, Farhad Ravandi, et al.
Haematologica|August 10, 2012
Phase 1 study of an anti-CD33 immunotoxin, humanized monoclonal antibody M195 conjugated to recombinant gelonin (HUM-195/rGEL), in patients with advanced myeloid malignanciesGautam Borthakur, Michael G Rosenblum, Moshe Talpaz, et al.
American Journal of Hematology|November 2, 2012
FLT3 mutations in myelodysplastic syndrome and chronic myelomonocytic leukemiaNaval Daver, Paolo Strati, Elias Jabbour, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 23, 2016
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal DysfunctionKoji Sasaki, Amit Lahoti, Elias Jabbour, et al.
Leukemia Research|July 18, 2015
Therapeutic benefit of decitabine, a hypomethylating agent, in patients with high-risk primary myelofibrosis and myeloproliferative neoplasm in accelerated or blastic/acute myeloid leukemia phaseTalha Badar, Hagop M Kantarjian, Farhad Ravandi, et al.
The Lancet. Haematology|May 31, 2025
Bexmarilimab plus azacitidine for high-risk myelodysplastic syndrome and relapsed or refractory acute myeloid leukaemia: results from the dose-escalation part of a multicentre, single-arm, phase 1/2 trialMika Kontro, Anthony Selwyn Stein, Marja Pyörälä, et al.
American Journal of Hematology|March 4, 2015
The clinical significance of negative flow cytometry immunophenotypic results in a morphologically scored positive bone marrow in patients following treatment for acute myeloid leukemiaJuan Ouyang, Maitrayee Goswami, Guilin Tang, et al.
Frontiers in Oncology|April 26, 2021
IDH1/IDH2 Inhibition in Acute Myeloid LeukemiaClaudio Cerchione, Alessandra Romano, Naval Daver, et al.
Haematologica|February 16, 2015
Final report of a phase II study of imatinib mesylate with hyper-CVAD for the front-line treatment of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemiaNaval Daver, Deborah Thomas, Farhad Ravandi, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|January 9, 2019
Leukemic Involvement in the ThoraxGirish S Shroff, Mylene T Truong, Brett W Carter, et al.
Pageof 38